Bulletin
Investor Alert

Urovant Sciences Ltd.

NAS: UROV

GO
/marketstate/country/us

Market closed

/zigman2/quotes/202720952/composite

$

8.83

Change

-0.10 -1.12%

Volume

Volume 31,433

Sep 23, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202720952/composite

Previous close

$ 8.93

$ 8.83

Change

-0.10 -1.12%

Day low

Day high

$8.75

$9.18

Open
Open: 8.90

52 week low

52 week high

$6.55

$15.98

Open

Market cap

$278.45M

Average volume

86,670

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-4.87

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/urov

MarketWatch News on UROV

  1. Urovant Sciences started at buy with $24 stock price target at SunTrust RH

    9:41 a.m. March 15, 2019

    - Tomi Kilgore

  2. Urovant Sciences started at overweight with $21 stock price target at J.P. Morgan

    7:23 a.m. Oct. 22, 2018

    - Tomi Kilgore

/news/nonmarketwatch/company/us/urov

Other News on UROV

  1. 10-Q: UROVANT SCIENCES LTD.

    5:08 p.m. Aug. 13, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. 10-K: UROVANT SCIENCES LTD.

    5:05 p.m. June 19, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. Why Urovant Sciences Is Likely A Better Bet Than Evofem

    3:37 p.m. May 27, 2020

    - Seeking Alpha

  4. Stocks To Watch: Time For Coronavirus Offense Or Defense?

    9:26 a.m. Feb. 29, 2020

    - Seeking Alpha

  5. 10-Q: UROVANT SCIENCES LTD.

    6:10 p.m. Feb. 13, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. Data published on Urovant gene therapy for overactive bladder

    9:22 a.m. Feb. 4, 2020

    - Seeking Alpha

  7. Company News For Jan 2, 2020

    11:19 a.m. Jan. 2, 2020

    - Zacks.com

  8. Urovant secures $300M capital raise

    9:51 a.m. Dec. 30, 2019

    - Seeking Alpha

  9. 10-Q: UROVANT SCIENCES LTD.

    6:05 p.m. Nov. 7, 2019

    - Edgar Online - (EDG = 10Q, 10K)

  10. Loading more headlines...
/news/pressrelease/company/us/urov

Press Releases on UROV

  1. Urovant Sciences Reports Fiscal First Quarter 2020 Results

    4:05 p.m. Aug. 13, 2020

    - BusinessWire - BZX

  2. Urovant Sciences to Report Fiscal Year and Fourth Quarter 2019 Results

    8:00 a.m. June 11, 2020

    - BusinessWire - BZX

  3. Urovant Sciences Appoints James Hindman to Board of Directors

    8:00 a.m. May 27, 2020

    - BusinessWire - BZX

  4. Urovant Sciences Reports 2019 Third Fiscal Quarter Financial Results

    5:15 p.m. Feb. 13, 2020

    - BusinessWire - BZX

  5. Urovant Sciences to Ring the Nasdaq Stock Market Opening Bell

    9:00 a.m. Jan. 17, 2020

    - BusinessWire - BZX

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.